| NDC Code | 16571-767-03 |
|---|
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16571-767-03) |
|---|
| Product NDC | 16571-767 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Darifenacin |
|---|
| Non-Proprietary Name | Darifenacin |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20160919 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA206743 |
|---|
| Manufacturer | Rising Pharma Holdings, Inc. |
|---|
| Substance Name | DARIFENACIN HYDROBROMIDE |
|---|
| Strength | 7.5 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
|---|